Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboprost methylate for cervical pretreatment before hysteroscopic diagnosis
ChiCTR-TRC-14004590Phase 4Completed
- Sponsor
- Beijing Obstetrics and Gynecology Hospital
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial comparing Methyl carprost suppository group with Placebo group (2 arms). Primary endpoints: Cervical dilation and Adverse drug reaction. Started Jun 2014; status: completed.
02
Drugs
Carboprost Methylate
Beyond the preview
Go deeper on ChiCTR-TRC-14004590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004590.